Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 56 ()
DOP11: Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitisECCO '19
Year: 2019
Authors: Stephanie Slevin
Ulcerative colitis, Immunology, Lymphocyte, T cell
Files: 1
DOP15: Metabolomics coupled with pathway analysis characterize metabolic changes in treatment-naive Ulcerative Colitis patientsECCO '19
Year: 2019
Authors: Joseph Diab
Ulcerative colitis, Immunology, Metabolomics
Files: 1
DOP17: AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of Inflammatory Bowel Disease (IBD)ECCO '19
Year: 2019
Authors: Mei Wang
JAK inhibitors, Immunology, Lymphocyte, T cell
Files: 1
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids,ECCO '19
Year: 2019
Authors: Kohei Suzuki
Epithelial cell
Files: 1
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s diseaseECCO '19
Year: 2019
Authors: Catherine Le Berre
Ileo caecal resection, Post operative complications, Post operative medical management, Post-operative IBD, Immunology, Lymphocyte, T cell
Files: 1
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesisECCO '19
Year: 2019
Authors: Bruce Weder
Fibroblast, Fibrosis
Files: 1
DOP25: Unraveling Vedolizumab mechanism of action in Ulcerative ColitisECCO '19
Year: 2019
Authors: Marisol Veny
Vedolizumab, Lymphocyte
Files: 1
DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patientsECCO '19
Year: 2019
Authors: Brecht Creyns
Immunology, Innate lymphoid cell, Lymphocyte
Files: 1
DOP28: Maternal obstetric outcomes in women with IBD compared to the general populationECCO '19
Year: 2019
Authors: Gillian Lever
IBD in pregnancy
Files: 1
DOP30: Factors associated with life satisfaction in people with Crohn's Disease and Ulcerative ColitisECCO '19
Year: 2019
Authors: Georgina Rowse
Crohn’s disease, Ulcerative colitis, Quality of life (IBDQ), Psychological co-morbidity, 13Psychological co-morbidity, Coping
Files: 1
DOP31: Development and validation of the IBD-REFER criteriaECCO '19
Year: 2019
Authors: Dan Turner
Files: 1
DOP32: Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenanceECCO '19
Year: 2019
Authors: Tadakazu Hisamatsu
Adalimumab, Anti-TNF agents, Thiopurines (AZA / MP), Disease activity indices, Mucosal healing
Files: 1
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease ECCO '19
Year: 2019
Authors: Claire Liefferinckx
Ustekinumab, Real world data
Files: 1
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitisECCO '19
Year: 2019
Authors: Marina Aloi
Montreal Classification, Paediatric
Files: 1
DOP36: Gut microbial variations in patients with quiescent Crohns disease predict subsequent disease flareECCO '19
Year: 2019
Authors: Yael Haberman
Microbiota, Crohn’s disease, Calprotectin and other faecal biomarkers, CRP and other serum biomarkers, Prognosis, Microbiota
Files: 1
Page: () 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 56 ()